Alan Kaganov

Alan L. Kaganov， Sc.D， joined US Venture Partners in July 1996， as a Partner， after 25 years of operating experience in the healthcare industry. At USVP， Dr. Kaganov focuses on investments in medical devices， drug-device combinations， drug delivery systems， and biopharmaceuticals.

Alan takes pride in coaching. Many healthcare companies begin with a great founding physician， or strong engineers， or solid intellectual property， but they don't necessarily have an experienced leader. Alan enjoys providing the mentoring function that so many people have provided to him. He adds value by teaching entrepreneurial founders to think strategically about their new business， about the environment in which they will compete， and how they can gain competitive advantage. The entrepreneurs of the world have special drives and needs - they're competitive， high energy， multi-tasking， and persistent in their determination to make change happen. That describes venture capitalists like Alan， too.

Prior to joining USVP， Dr. Kaganov led Business Development and Strategic Planning at Boston Scientific Corporation. Prior to BSC， he was CEO of EP Technologies， and transformed the Company into the recognized leader in catheter-based arrhythmia treatment. Prior to this， Dr. Kaganov spent six years at Baxter International as Vice President of Technology and Business Development， and as General Manager， Fenwal Division.

Alan earned a B.S. in Mechanical Engineering from Duke University， an M.S. and Sc.D. in Biomedical Engineering from Columbia University， and an M.B.A. from New York University. Alan received a Career Fellowship from the National Institutes of Health in Biomedical Engineering.